share_log

Analyst Expectations for ADC Therapeutics's Future

Benzinga ·  11/21/2023 00:00

Within the last quarter, ADC Therapeutics (NYSE:ADCT) has observed the following analyst ratings: These 4 analysts have an average price target of $7.25 versus the current price of ADC Therapeutics at $0.6935, implying upside.Below is a summary of how these 4 analysts rated ADC Therapeutics over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stockThis current average represents a 22.29% decrease from the previous average price target of $9.33. Stay up to date on ADC Therapeutics analyst ratings.If

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment